What is NDC 68462-325?

68462-325 is the product NDC for indomethacin, Indomethacin 75 mg/1 capsule, extended release, listed with the FDA by Glenmark Pharmaceuticals Inc., USA. It has 5 package NDCs, shown above in 10- and 11-digit form.

Glenmark Pharmaceuticals Inc., USA, NDC labeler code 68462. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for indomethacin?

79 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

indomethacin NDC 68462-325 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)68462-325Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68462-0325Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
68462-325-01	6846203250168462032501	100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-325-01)Marketed from Jun 22, 2017
68462-325-05	6846203250568462032505	500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-325-05)Marketed from Jun 22, 2017
68462-325-10	6846203251068462032510	1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-325-10)Marketed from Jun 22, 2017
68462-325-60	6846203256068462032560	60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-325-60)Marketed from Jun 22, 2017
68462-325-90	6846203259068462032590	90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-325-90)Marketed from Jun 22, 2017

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): indomethacin
Generic name (nonproprietary): indomethacin
Active ingredients: Indomethacin — 75 mg/1
Dosage form: Capsule, Extended release
Route: Oral
Labeler: Glenmark Pharmaceuticals Inc., USANDC labeler code 68462
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 203501
Marketing start: Jun 22, 2017
Listing expires: Dec 31, 2027
Other FDA classes: Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)
Identifiers: Product ID 68462-325_e729f88c-b2c8-4462-98be-7184de95b01dSPL ID e729f88c-b2c8-4462-98be-7184de95b01dSPL set ID 532d40b2-c05c-4d4f-b7ee-e6434c4c27fcRxCUI 310992UNII XXE1CET956UPC 0368462325605
Pharmacologic class: Nonsteroidal Anti-inflammatory Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468462032501 followed by a unit qualifier and the quantity

Package 68462-0325-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 3, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Indomethacin extended-release capsules are indicated for: • Moderate to severe rheumatoid arthritis including acute flares of chronic disease • Moderate to severe ankylosing spondylitis • Moderate to severe osteoarthritis • Acute painful shoulder (bursitis and/or tendinitis) Indomethacin extended-release capsules are a nonsteroidal anti-inflammatory drug indicated for: • Moderate to severe rheumatoid arthritis including acute flares of chronic disease • Moderate to severe ankylosing spondylitis • Moderate to severe osteoarthritis • Acute painful shoulder (bursitis and/or tendinitis) ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 68462-325

What is NDC 68462-325?: 68462-325 is the product NDC for indomethacin, Indomethacin 75 mg/1 capsule, extended release, listed with the FDA by Glenmark Pharmaceuticals Inc., USA. It has 5 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: indomethacin.
What is the active ingredient?: Indomethacin.
Who is the labeler?: Glenmark Pharmaceuticals Inc., USA, NDC labeler code 68462. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for indomethacin?: 79 other product NDCs are listed under this name. See all indomethacin NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other indomethacin NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Indomethacin	Indomethacin 50 mg/1	CapsuleOral	Coupler LLC	67046-0416	67046-0416-03
Indomethacin	Indomethacin 50 mg/1	SuppositoryRectal	NorthStar RxLLC	72603-281	72603-0281-30
Indomethacin	Indomethacin 50 mg/1	CapsuleOral	Preferred Pharmaceuticals Inc.	68788-4055	68788-4055-03
Indomethacin	Indomethacin 50 mg/1	SuppositoryRectal	Camber Pharmaceuticals, Inc.	31722-051	31722-0051-31
Indomethacin	Indomethacin 50 mg/1	SuppositoryRectal	Amneal Pharmaceuticals NY LLC	69238-2086	69238-2086-03
Indomethacin	Indomethacin 50 mg/1	SuppositoryRectal	Hikma Pharmaceuticals USA Inc.	0054-1950	00054-1950-30
Indomethacin	Indomethacin 50 mg/1	CapsuleOral	St. Mary's Medical Park Pharmacy	60760-916	60760-0916-2160760-0916-30
Indomethacin	Indomethacin 50 mg/1	SuppositoryRectal	Zydus Pharmaceuticals USA Inc.	70710-1958	70710-1958-07
Indomethacin	Indomethacin 25 mg/5mL	SuspensionOral	ANI Pharmaceuticals, Inc.	70954-637	70954-0637-10
Indomethacin	Indomethacin 50 mg/1	SuppositoryRectal	Zydus Pharmaceuticals USA Inc.	70710-1852	70710-1852-07

All 80 indomethacin NDCs